A simple finger prick could replace blood draws for cancer drug monitoring
NCT ID NCT05598788
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a tiny finger-prick blood sample can accurately measure levels of nine oral cancer drugs, compared to standard blood draws. Researchers will enroll 160 patients taking one of these drugs. If the microsampling method works, it could offer a less invasive way to personalize dosing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If validated, this finger-prick method could make it easier and less painful to monitor drug levels in cancer patients, potentially improving personalized dosing.
What could go wrong
This is an observational validation study, not a treatment trial. The microsampling technique may not prove accurate enough for routine clinical use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD CONCENTRATIONS OF NINE ANTI-CANCER DRUGS : AXITINIB, OLAPARIB, REGORAFÉNIB, CABOZANTINIB, NIRAPARIB, TALAZOPARIB, PALBOCICLIB, ABEMACICLIB, TUCATINIB are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Eugène Marquis Unicancer
Rennes, 35000, France
-
Institut de cancérologie Strasbourg Europe
Strasbourg, 67033, France
-
Rennes University Hospital
Rennes, 35000, France